Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fraia Melchionda

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Pediatric Reports|February 23, 2012
Negative pressure treatment for necrotizing fasciitis after chemotherapyFraia Melchionda, Andrea Pession
Biologics : Targets & Therapy|August 27, 2009
Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase)Andrea Pession, Fraia Melchionda, Claudia Castellini
Translational Pediatrics|February 3, 2016
Stage I clear cell sarcoma of the kidney: is it the time for a less intensive adjuvant treatment?Filippo Spreafico, Lorenza Gandola, Fraia Melchionda
Biomed Research International|December 23, 2016
Synergistic Cytotoxic Effect of L-Asparaginase Combined with Decitabine as a Demethylating Agent in Pediatric T-ALL, with Specific Epigenetic SignatureSalvatore Serravalle, Salvatore N Bertuccio, Annalisa Astolfi, et al.
Epigenomics|June 1, 2019
BCOR involvement in cancerAnnalisa Astolfi, Michele Fiore, Fraia Melchionda, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 18, 2004
Escape from immune surveillance does not result in tolerance to tumor-associated antigensFraia Melchionda, Melissa K McKirdy, Filomena Medeiros, et al.
Cells|April 27, 2026
Endocrine Late Effects of Targeted and Immune-Based Therapies in Pediatric OncologyVittorio Ferrari, Alice Ranieri, Alessandro Ruggi, et al.
Cancers|November 27, 2021
High Grade of Amplification of Six Regions on Chromosome 2p in a Neuroblastoma Patient with Very Poor Outcome: The Putative New Oncogene <i>TSSC1</i>Marzia Ognibene, Loredana Amoroso, Fraia Melchionda, et al.
Cancer Immunology, Immunotherapy : CII|December 7, 2006
Immune reconstitution prevents metastatic recurrence of murine osteosarcomaMelinda S Merchant, Fraia Melchionda, Manoj Sinha, et al.
Journal of Pediatric Hematology/Oncology|September 6, 2021
Hemiplegic-Migraine-like Attacks as First Manifestation of Diffuse Leptomeningeal Glioneuronal Tumor: A Case ReportAnna Fetta, Jacopo Pruccoli, Giacomo Biasucci, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Pediatric Reports|February 23, 2012
Negative pressure treatment for necrotizing fasciitis after chemotherapyFraia Melchionda, Andrea Pession
Biologics : Targets & Therapy|August 27, 2009
Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase)Andrea Pession, Fraia Melchionda, Claudia Castellini
Translational Pediatrics|February 3, 2016
Stage I clear cell sarcoma of the kidney: is it the time for a less intensive adjuvant treatment?Filippo Spreafico, Lorenza Gandola, Fraia Melchionda
Biomed Research International|December 23, 2016
Synergistic Cytotoxic Effect of L-Asparaginase Combined with Decitabine as a Demethylating Agent in Pediatric T-ALL, with Specific Epigenetic SignatureSalvatore Serravalle, Salvatore N Bertuccio, Annalisa Astolfi, et al.
Epigenomics|June 1, 2019
BCOR involvement in cancerAnnalisa Astolfi, Michele Fiore, Fraia Melchionda, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 18, 2004
Escape from immune surveillance does not result in tolerance to tumor-associated antigensFraia Melchionda, Melissa K McKirdy, Filomena Medeiros, et al.
Cells|April 27, 2026
Endocrine Late Effects of Targeted and Immune-Based Therapies in Pediatric OncologyVittorio Ferrari, Alice Ranieri, Alessandro Ruggi, et al.
Cancers|November 27, 2021
High Grade of Amplification of Six Regions on Chromosome 2p in a Neuroblastoma Patient with Very Poor Outcome: The Putative New Oncogene <i>TSSC1</i>Marzia Ognibene, Loredana Amoroso, Fraia Melchionda, et al.
Cancer Immunology, Immunotherapy : CII|December 7, 2006
Immune reconstitution prevents metastatic recurrence of murine osteosarcomaMelinda S Merchant, Fraia Melchionda, Manoj Sinha, et al.
Journal of Pediatric Hematology/Oncology|September 6, 2021
Hemiplegic-Migraine-like Attacks as First Manifestation of Diffuse Leptomeningeal Glioneuronal Tumor: A Case ReportAnna Fetta, Jacopo Pruccoli, Giacomo Biasucci, et al.
Pageof 5